Leveraging the power of automation to boost research

In this interview, NewsMedical talks to Cerba’s Lukasz Wulnikowski about the power of automation and how it has drastically changed the way the company approaches kit building lines.

New Option Approved for Erosive Esophagitis

The FDA approved vonoprazan (Voquezna) for all grades of erosive gastroesophageal reflux disease (GERD) and heartburn relief associated with the condition, Phathom Pharmaceuticals announced on

November 3, 2023

FDA approves latest Covid vaccines, and Harris makes her case

Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Happy Friday! Isa here. As a Floridian, my

August 23, 2024

Will Congress get any health policy done this year?

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.